{"entity":{"type":"insider","cik":"0001263197","url":"/insider/0001263197","json_url":"/insider/0001263197.json","name":"BAB BIO VENTURES LLP","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":45,"n_filings":8,"first":"2004-07-28","last":"2008-06-23","span_basis":"filed_date"},"name_variants":[{"name":"BAB BIO VENTURES LLP","source":"filing","n_filings":8,"first_seen":"2004-07-28","last_seen":"2008-06-23"}],"transactions":[{"id":3612974,"accession":"0001209191-08-038435","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-08-038435","line_url":"/filing/0001209191-08-038435","is_derivative":false,"issuer_cik":"0001040662","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001040662","owner_cik":null,"owner_name":"MPM ASSET MANAGEMENT INVESTORS 1999 LLC; STEINMETZ MICHAEL; BAB BIO VENTURES NV; MPM BIOVENTURES PARALLEL FUND L P; MPM BIO VENTURES I LLC; BAB BIO VENTURES LLP; BB BIOVENTURES L P; MPM BIOVENTURES I LP; GADICKE ANSBERT","owner_display_name":"MPM ASSET MANAGEMENT INVESTORS 1999 LLC","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":155800.0,"shares_display":"155,800","price_per_share":19.90096919127086,"price_display":"19.90","price_state":"stated","total_value":3100571.0,"total_display":"3,100,571.00","total_whole":"3,100,571","shares_owned_after":2120431.0,"shares_owned_after_display":"2,120,431","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-06-19","filed_date":"2008-06-23","scope":"insider","n_lines":5},{"id":2811233,"accession":"0001209191-08-037925","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-08-037925","line_url":"/filing/0001209191-08-037925","is_derivative":false,"issuer_cik":"0001040662","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001040662","owner_cik":null,"owner_name":"BB BIOVENTURES L P; MPM BIOVENTURES I LP; BAB BIO VENTURES LLP; GADICKE ANSBERT; STEINMETZ MICHAEL; MPM BIO VENTURES I LLC; EVNIN LUKE; MPM ASSET MANAGEMENT INVESTORS 1999 LLC; BAB BIO VENTURES NV; MPM BIOVENTURES PARALLEL FUND L P","owner_display_name":"BB BIOVENTURES L P","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":101900.0,"shares_display":"101,900","price_per_share":20.15189401373896,"price_display":"20.15","price_state":"stated","total_value":2053478.0,"total_display":"2,053,478.00","total_whole":"2,053,478","shares_owned_after":2276231.0,"shares_owned_after_display":"2,276,231","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-06-17","filed_date":"2008-06-18","scope":"insider","n_lines":4},{"id":3549582,"accession":"0001209191-08-037926","txn_seq":28,"anchor":"line-28","filing_url":"/filing/0001209191-08-037926","line_url":"/filing/0001209191-08-037926","is_derivative":false,"issuer_cik":"0001040662","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001040662","owner_cik":null,"owner_name":"EVNIN LUKE; GADICKE ANSBERT; BAB BIO VENTURES LLP; MPM ASSET MANAGEMENT INVESTORS 1999 LLC; MPM BIO VENTURES I LLC; BAB BIO VENTURES NV; MPM BIOVENTURES PARALLEL FUND L P; BB BIOVENTURES L P; MPM BIOVENTURES I LP; STEINMETZ MICHAEL","owner_display_name":"EVNIN LUKE","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":281149.0,"shares_display":"281,149","price_per_share":20.134426727464795,"price_display":"20.13","price_state":"stated","total_value":5660773.94,"total_display":"5,660,773.94","total_whole":"5,660,774","shares_owned_after":2473593.0,"shares_owned_after_display":"2,473,593","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-06-16","filed_date":"2008-06-18","scope":"insider","n_lines":28},{"id":3996467,"accession":"0001209191-08-009087","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-08-009087","line_url":"/filing/0001209191-08-009087#line-2","is_derivative":false,"issuer_cik":"0001040662","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001040662","owner_cik":null,"owner_name":"EVNIN LUKE; BB BIOVENTURES L P; MPM BIOVENTURES I LP; MPM ASSET MANAGEMENT INVESTORS 1999 LLC; BAB BIO VENTURES NV; MPM BIOVENTURES PARALLEL FUND L P; MPM BIO VENTURES I LLC; GADICKE ANSBERT; BAB BIO VENTURES LLP; STEINMETZ MICHAEL","owner_display_name":"EVNIN LUKE","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27925.0,"shares_display":"27,925","price_per_share":21.36,"price_display":"21.36","price_state":"stated","total_value":596478.0,"total_display":"596,478.00","total_whole":"596,478","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-02-08","filed_date":"2008-02-11","scope":"insider"},{"id":3996466,"accession":"0001209191-08-009087","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-08-009087","line_url":"/filing/0001209191-08-009087#line-1","is_derivative":false,"issuer_cik":"0001040662","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001040662","owner_cik":null,"owner_name":"EVNIN LUKE; BB BIOVENTURES L P; MPM BIOVENTURES I LP; MPM ASSET MANAGEMENT INVESTORS 1999 LLC; BAB BIO VENTURES NV; MPM BIOVENTURES PARALLEL FUND L P; MPM BIO VENTURES I LLC; GADICKE ANSBERT; BAB BIO VENTURES LLP; STEINMETZ MICHAEL","owner_display_name":"EVNIN LUKE","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":36664.0,"shares_display":"36,664","price_per_share":23.02,"price_display":"23.02","price_state":"stated","total_value":844005.28,"total_display":"844,005.28","total_whole":"844,005","shares_owned_after":2587168.0,"shares_owned_after_display":"2,587,168","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-02-07","filed_date":"2008-02-11","scope":"insider"},{"id":3420326,"accession":"0001209191-08-008192","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-08-008192","line_url":"/filing/0001209191-08-008192#line-5","is_derivative":false,"issuer_cik":"0001040662","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001040662","owner_cik":null,"owner_name":"BAB BIO VENTURES NV; MPM BIOVENTURES PARALLEL FUND L P; STEINMETZ MICHAEL; GADICKE ANSBERT; MPM ASSET MANAGEMENT INVESTORS 1999 LLC; EVNIN LUKE; BAB BIO VENTURES LLP; MPM BIO VENTURES I LLC; BB BIOVENTURES L P; MPM BIOVENTURES I LP","owner_display_name":"BAB BIO VENTURES NV","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27300.0,"shares_display":"27,300","price_per_share":23.86,"price_display":"23.86","price_state":"stated","total_value":651378.0,"total_display":"651,378.00","total_whole":"651,378","shares_owned_after":2623832.0,"shares_owned_after_display":"2,623,832","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-02-04","filed_date":"2008-02-06","scope":"insider"},{"id":6916965,"accession":"0001209191-07-028012","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-07-028012","line_url":"/filing/0001209191-07-028012#line-4","is_derivative":false,"issuer_cik":"0001040662","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001040662","owner_cik":null,"owner_name":"EVNIN LUKE; BB BIOVENTURES L P; MPM BIOVENTURES I LP; MPM ASSET MANAGEMENT INVESTORS 1999 LLC; BAB BIO VENTURES NV; MPM BIOVENTURES PARALLEL FUND L P; MPM BIO VENTURES I LLC; BAB BIO VENTURES LLP; STEINMETZ MICHAEL","owner_display_name":"EVNIN LUKE","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":277777.0,"shares_display":"277,777","price_per_share":9.0,"price_display":"9.00","price_state":"stated","total_value":2499993.0,"total_display":"2,499,993.00","total_whole":"2,499,993","shares_owned_after":4094500.0,"shares_owned_after_display":"4,094,500","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-05-02","filed_date":"2007-05-04","scope":"insider"},{"id":1281280,"accession":"0001209191-05-043265","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-05-043265","line_url":"/filing/0001209191-05-043265#line-3","is_derivative":false,"issuer_cik":"0000356830","issuer_name":"OSCIENT PHARMACEUTICALS CORP","issuer_ticker":"OSCI","issuer_name_source":null,"issuer_url":"/issuer/0000356830","owner_cik":null,"owner_name":"EVNIN LUKE; BB BIOVENTURES L P; BAB BIO VENTURES LLP; BAB BIO VENTURES NV; MPM BIO VENTURES PARALLEL FUND L P; MPM ASSET MANAGEMENT INVESTORS 1998 LLC/MA; GADICKE ANSBERT; MPM BIO VENTURES I LLC; MPM BIO VENTURES I LP; STEINMETZ MICHAEL","owner_display_name":"EVNIN LUKE","owner_url":null,"role":"Director, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":160000.0,"shares_display":"160,000","price_per_share":2.6615,"price_display":"2.66","price_state":"stated","total_value":425840.0,"total_display":"425,840.00","total_whole":"425,840","shares_owned_after":7172050.0,"shares_owned_after_display":"7,172,050","ownership_form":"I","is_10b5_1":null,"transaction_date":"2005-08-17","filed_date":"2005-08-17","scope":"insider"},{"id":1281279,"accession":"0001209191-05-043265","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-05-043265","line_url":"/filing/0001209191-05-043265#line-2","is_derivative":false,"issuer_cik":"0000356830","issuer_name":"OSCIENT PHARMACEUTICALS CORP","issuer_ticker":"OSCI","issuer_name_source":null,"issuer_url":"/issuer/0000356830","owner_cik":null,"owner_name":"EVNIN LUKE; BB BIOVENTURES L P; BAB BIO VENTURES LLP; BAB BIO VENTURES NV; MPM BIO VENTURES PARALLEL FUND L P; MPM ASSET MANAGEMENT INVESTORS 1998 LLC/MA; GADICKE ANSBERT; MPM BIO VENTURES I LLC; MPM BIO VENTURES I LP; STEINMETZ MICHAEL","owner_display_name":"EVNIN LUKE","owner_url":null,"role":"Director, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":150000.0,"shares_display":"150,000","price_per_share":2.6424,"price_display":"2.64","price_state":"stated","total_value":396360.0,"total_display":"396,360.00","total_whole":"396,360","shares_owned_after":7332050.0,"shares_owned_after_display":"7,332,050","ownership_form":"I","is_10b5_1":null,"transaction_date":"2005-08-16","filed_date":"2005-08-17","scope":"insider"},{"id":1281278,"accession":"0001209191-05-043265","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-05-043265","line_url":"/filing/0001209191-05-043265#line-1","is_derivative":false,"issuer_cik":"0000356830","issuer_name":"OSCIENT PHARMACEUTICALS CORP","issuer_ticker":"OSCI","issuer_name_source":null,"issuer_url":"/issuer/0000356830","owner_cik":null,"owner_name":"EVNIN LUKE; BB BIOVENTURES L P; BAB BIO VENTURES LLP; BAB BIO VENTURES NV; MPM BIO VENTURES PARALLEL FUND L P; MPM ASSET MANAGEMENT INVESTORS 1998 LLC/MA; GADICKE ANSBERT; MPM BIO VENTURES I LLC; MPM BIO VENTURES I LP; STEINMETZ MICHAEL","owner_display_name":"EVNIN LUKE","owner_url":null,"role":"Director, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":2.607,"price_display":"2.61","price_state":"stated","total_value":130350.0,"total_display":"130,350.00","total_whole":"130,350","shares_owned_after":7482050.0,"shares_owned_after_display":"7,482,050","ownership_form":"I","is_10b5_1":null,"transaction_date":"2005-08-15","filed_date":"2005-08-17","scope":"insider"},{"id":236350,"accession":"0001209191-04-037837","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-04-037837","line_url":"/filing/0001209191-04-037837#line-1","is_derivative":false,"issuer_cik":"0001040662","issuer_name":"IDENIX PHARMACEUTICALS INC","issuer_ticker":"IDIX","issuer_name_source":null,"issuer_url":"/issuer/0001040662","owner_cik":null,"owner_name":"BAB BIO VENTURES NV; STEINMETZ MICHAEL; EVNIN LUKE; MPM BIO VENTURES PARALLEL FUND L P; BB BIOVENTURES L P; MPM BIO VENTURES I LLC; MPM BIO VENTURES I LP; MPM ASSET MANAGEMENT LLC; MPM ASSET MANAGEMENT INVESTORS 1998 LLC/MA; BAB BIO VENTURES LLP","owner_display_name":"BAB BIO VENTURES NV","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":508371.0,"shares_display":"508,371","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":7117194.0,"total_display":"7,117,194.00","total_whole":"7,117,194","shares_owned_after":4797991.0,"shares_owned_after_display":"4,797,991","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-07-27","filed_date":"2004-07-28","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001301081","name":"Pharmasset Inc","url":"/issuer/0001301081","role":"Ten percent owner, Other","n_filings":6,"first_seen":"2007-05-04","last_seen":"2008-06-23"},{"type":"issuer","type_label":"ISSUER","cik":"0000356830","name":"OSCIENT PHARMACEUTICALS CORP","url":"/issuer/0000356830","role":"Other","n_filings":1,"first_seen":"2005-08-17","last_seen":"2005-08-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001093649","name":"IDENIX PHARMACEUTICALS INC","url":"/issuer/0001093649","role":"Ten percent owner","n_filings":1,"first_seen":"2004-07-28","last_seen":"2004-07-28"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001263197","retrieved_at":"2026-08-22T19:55:36+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}